This 240-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.
The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 240 pages and 23 tables